GCP ClinPlus offers end-to-end infectious disease clinical trials solutions across the full spectrum of anti-infective therapies, including vaccines, antivirals, and antibiotics. With over 23 years of focused experience and a proven pandemic response framework, we help sponsors accelerate development with speed, quality, and regulatory confidence. Our programs align with WHO prequalification standards and have supported major global trials—such as a Phase III, multi-country COVID-19 vaccine study. Delivering What Matters to Biopharma GCP ClinPlus is a leading Infectious Disease CRO in China in anti-infective research, offering agile, full-lifecycle clinical development services that accelerate time to market for vaccines, antivirals, antibiotics, and ...

Lire la suite

GCP ClinPlus offers end-to-end clinical development services in neuroscience, with a strong focus on Alzheimer's disease, depression, and rare neurological disorders such as SMA and ALS. Equipped with China CNS CRO-specific cognitive assessment tools (e.g., ADAS-Cog) and CSF biomarker testing protocols, we address common challenges such as placebo effect bias and endpoint variability. With deep therapeutic expertise and operational excellence, we help sponsors advance safe and effective neurological therapies through every stage of development. Delivering What Matters to Biopharma With a deep commitment to innovation and patient-centered research, GCP ClinPlus is a proven China Neurology CRO partner in the ...

Lire la suite

With over 23 years of experience in oncology research and clinical trial operations, GCP ClinPlus is a trusted CRO partner in the development of innovative cancer therapies. We specialize in hematologic malignancies, solid tumors, and immuno-oncology, providing full-spectrum liver cancer drug trials services from early-phase studies to post-marketing research. Collaborating with 80% of China's leading oncology hospitals, we help sponsors achieve accelerated, high-quality outcomes across all phases of development.   Delivering What Matters to Biopharma GCP ClinPlus is a recognized leader in oncology clinical research, offering end-to-end Liver disease CRO  services tailored to the complexity of cancer drug development.   Scientific rigor and uncompromising ...

Lire la suite

GCP ClinPlus offers comprehensive clinical trial services across the full lifecycle of drug development in rheumatology, from Phase I–III studies to post-marketing research. With extensive expertise in autoimmune and inflammatory disorders, we support trials in ankylosing spondylitis, rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, psoriasis, inflammatory bowel disease (IBD), and more. Our integrated approach ensures scientific rigor, regulatory compliance, and operational excellence.   Delivering What Matters to Biopharma With deep scientific grounding and rich operational experience, GCP ClinPlus has built a reputation as a trusted Immunology CRO in China partner in rheumatology clinical research.   Delivering What Matters to Biopharma We ...

Lire la suite